The Importance of Autophagy Regulation in Breast Cancer Development and Treatment

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Zarzynska, Joanna Magdalena ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BECLIN 1; CYTOPROTECTIVE AGENT; CYTOSTATIC AGENT; ETOPOSIDE; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER CELL; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER THERAPY; CELL DEATH; CELL PROTECTION; CELL TRANSFORMATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CYTOTOXICITY; GENE SILENCING; HUMAN; IONIZING RADIATION; MACROAUTOPHAGY; MOLECULAR BIOLOGY; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); REGULATORY MECHANISM; REVIEW; THERAPY EFFECT; TUMOR VOLUME; BREAST NEOPLASMS; CARCINOGENESIS; DRUG EFFECTS; FEMALE; GENETICS; PATHOLOGY;

ANTINEOPLASTIC AGENTS; AUTOPHAGY; BREAST NEOPLASMS; CARCINOGENESIS; FEMALE; HUMANS;

EID: 84925334670     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/710345     Document Type: Review

References (93)

1. J. H. Howard and K. I. Bland, "Current management and treatment strategies for breast cancer, " Current Opinion in Obstetrics and Gynecology, vol. 24, no. 1, pp. 44-48, 2012.
2. S. Kuger, E. Corek, B. Polat, U. Kammerer, M. Flentje, and C. S. Ddjuzenova, "Novel PI3K and mTOR Inhibitor NVP-BEZ235 radiosensitizes breast cancer cell lines under normoxic and hypoxic conditions, " BreastCancer: Basic and Clinical Research, vol. 8, no. 1, pp. 39-49, 2014.
3. M. Herranz and A. Ruibal, "Optical imaging in breast cancer diagnosis: the next evolution, " Journal of Oncology, Article ID 863747, 2012.
4. N. R. Shah and H. Chen, "MicroRNAs in pathogenesis of breast cancer: implications in diagnosis and treatment, " World Journal of Clinical Oncology, vol. 5, no. 2, pp. 48-60, 2014.
5. L. R. Gomes, L. F. Terra, R. A. M. Wailemann, L. Labriola, and M. C. Sogayar, "TGF-β1 modulates the homeostasis between MMPs and MMPinhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells, " BMC Cancer, vol. 12, article 26, 2012.
6. P. L. Porter, "Global trends in breast cancer incidence and mortality, " Salud Publica deMexico, vol. 51, no. 2, pp. S141-S146, 2009.
7. Y. Fang, Y. Chen, L. Yu, et al., "Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1, " Journal of the National Cancer Institute, vol. 105, no. 1, pp. 47-58, 2013.
8. F. E. Langlands, K. Horgan, D. D. Dodwell, and L. Smith, "Breast cancer subtypes: response to radiotherapy and potential radiosensitisation, " The British Journal of Radiology, vol. 86, no. 1023, Article ID20120601, 2013.
9. R. F. Prietsch, L. G. Monte, F. A. da Silva, et al., "Genistein induces apoptosis and autophagy in human breast MCF-7 cells by modulating the expression of proapoptotic factors and oxidative stress enzymes, " Molecular and Cellular Biochemistry, vol. 390, no. 1-2, pp. 235-242, 2014.
10. R. Siegel, D. Naishadham, and A. Jemal, "Cancer statistics, 2012, " CA Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10-29, 2012.
11. A. Bhardwaj, D. Rosen, M. Liu, et al., "Suppression of AktmTOR pathway-a novel component of oncogene induced DNA damage response barrier in breast tumorigenesis, " PLoS ONE, vol. 9, no. 5, Article ID e97076, 2014.
12. K. N. Dalby, I. Tekedereli, G. Lopez-Berestein, and B. Ozpolat, "Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer, " Autophagy, vol. 6, no. 3, pp. 322-329, 2010.
13. S. Cagnol and J. C. Chambard, "ERK and cell death: Mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence, " FEBS Journal, vol. 277, no. 1, pp. 2-21, 2010.
14. B. Levine and G. Kroemer, "Autophagy in the pathogenesis of disease, " Cell, vol. 132, no. 1, pp. 27-42, 2008.
15. P. Jiang and N. Mizushima, "Autophagy and human diseases, " Cell Research, vol. 24, no. 1, pp. 69-79, 2014.
16. E. White, "Deconvoluting the context-dependent role for autophagy in cancer, " Nature Reviews Cancer, vol. 12, no. 6, pp. 401-410, 2012.
17. R. Mathew, C. M. Karp, B. Beaudoin, et al., "Autophagy suppresses tumorigenesis through elimination of p62, " Cell, vol. 137, pp. 1062-1075, 2009.
18. C. Cerella, M.-H. Teiten, F. Radogna, M. Dicato, and M. Diederich, "From nature to bedside: pro-survival and cell death mechanisms as therapeutic targets in cancer treatment, " Biotechnology Advances, vol. 32, no. 6, pp. 1111-1122, 2014.
19. C. Fung, R. Lock, S. Gao, E. Salas, and J. Debnath, "Induction of autophagy during extracellular matrix detachment promotes cell survival, "Molecular Biology of the Cell, vol. 19, no. 3, pp. 797-806, 2008.
20. W. Martinet, P. Agostinis, B. Vanhoecke, M. Dewaele, and G. R. Y. deMeyer, "Autophagy in disease: a double-edged sword with therapeutic potential, " Clinical Science, vol. 116, no. 9, pp. 697-712, 2009.
21. V. Karantza-Wadsworth, S. Patel, O. Kravchuk, et al., "Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis, " Genes and Development, vol. 21, no. 13, pp. 1621-1635, 2007.
22. W. Chen, L. Zhang, K. Zhang, et al., "Reciprocal regulation of autophagy and dNTP pools in human cancer cells, " Autophagy, vol. 10, no. 7, pp. 1272-84, 2014.
23. G. Kroemer, G. Marino, and B. Levine, "Autophagy and the integrated stress response, " Molecular Cell, vol. 40, no. 2, pp. 280-293, 2010.
24. F. T. Andon and B. Fadeel, "Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials, " Accounts of Chemical Research, vol. 46, no. 3, pp. 733-742, 2013.
25. S. W. Ryter, S. M. Cloonan, and A. M. K. Choi, "Autophagy: a critical regulator of cellular metabolism and homeostasis, " Molecules and Cells, vol. 36, no. 1, pp. 7-16, 2013.
26. L. B. Frankel and A. H. Lund, "MicroRNA regulation of autophagy, " Carcinogenesis, vol. 33, no. 11, pp. 2018-2025, 2012.
27. M. U. Awan and Y. Deng, "Role of autophagy and its significance in cellular homeostasis, " Applied Microbiology and Biotechnology, vol. 98, no. 12, pp. 5319-5328, 2014.
28. D. M. Benbrook and A. Long, "Integration of autophagy, proteasomal degradation, unfolded protein response and apoptosis, " Experimental Oncology, vol. 34, no. 3, pp. 286-297, 2012.
29. Y. Chen, L. L. Fu, X. Wen, et al., "Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy, " Apoptosis, vol. 19, no. 8, pp. 1177-1189, 2014.
30. I. G. Ganley, D. H. Lam, J. Wang, X. Ding, S. Chen, and X. Jiang, "ULK1ATG13-FIP200 complex mediates mTOR signaling and is essential for autophagy, " The Journal of Biological Chemistry, vol. 284, no. 18, pp. 12297-12305, 2009.
31. C. H. Jung, C. B. Jun, S.-H. Ro, et al., "ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery, " Molecular Biology of the Cell, vol. 20, no. 7, pp. 1992-2003, 2009.
32. Y. Sancak, T. R. Peterson, Y. D. Shaul, et al., "The rag GTPases bind raptor and mediate amino acid signaling to mTORC1, " Science, vol. 320, no. 5882, pp. 1496-1501, 2008.
33. K. Inoki, J. Kim, and K.-L. Guan, "AMPK and mTOR in cellular energy homeostasis and drug targets, " Annual Review of Pharmacology and Toxicology, vol. 52, pp. 381-400, 2012.
34. C. Ferte, F. Andre, and J.-C. Soria, "Molecular circuits of solid tumors: prognostic and predictive tools for bedside use, " Nature Reviews Clinical Oncology, vol. 7, no. 7, pp. 367-380, 2010.
35. N. Chen and V. Karanza-Wadsworth, "Role and regulation of autophagy in cancer, " Biochimicaet Biophysica Acta, vol. 1793, no. 9, pp. 1516-1523, 2009.
36. S. Sahni, A. M. Merlot, S. Krishan, P. J. Jansson, and D. R. Richardson, "Gene of the month: BECN1, " Journal of Clinical Pathology, vol. 67, pp. 656-660, 2014.
37. Y. Zhong, Q. J. Wang, X. Li, et al., "Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex, " Nature Cell Biology, vol. 11, no. 4, pp. 468-476, 2009.
38. H. Wei, S. Wei, B. Gan, X. Peng, W. Zou, and J.-L. Guan, "Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis, "Genes and Development, vol. 25, no. 14, pp. 1510-1527, 2011.
39. M. V. Jain, A. M. Paczulla, T. Klonisch, et al., "Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development, " Journal of Cellular and Molecular Medicine, vol. 17, no. 1, pp. 12-29, 2013.
40. J. Debnath, "The multifaceted roles of autophagy in tumors-implications for breast cancer, " Journal of Mammary Gland Biology and Neoplasia, vol. 16, no. 3, pp. 173-187, 2011.
41. R. Lock, S. Roy, C. M. Kenific, et al., "Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation, " Molecular Biology of the Cell, vol. 22, no. 2, pp. 165-178, 2011.
42. M. Boyer-Guittaut, L. Poillet, Q. Liang, et al., "The role of GABARAPL1/GEC1 in autophagic flux and mitochondrial quality control in MDA-MB-436 breast cancer cells, " Autophagy, vol. 10, no. 6, pp. 986-1003, 2014.
43. Y. Cheng, X. Ren, W. N. Hait, and J.-M. Yang, "Therapeutic targeting of autophagy in disease: biology and pharmacology, " Pharmacological Reviews, vol. 65, no. 4, pp. 1162-1197, 2013.
44. T. Motyl, B. Gajkowska, J. Zarzynska, M. Gajewska, and M. Lamparska-Przybysz, "Apoptosis and autophagy in mammary gland remodeling and breast cancer chemotherapy, " Journal of Physiology and Pharmacology, vol. 57, no. 7, pp. 17-32, 2006.
45. J. Botti, M. Djavaheri-Mergny, Y. Pilatte, and P. Codogno, "Autophagy signaling and the cogwheels of cancer, " Autophagy, vol. 2, no. 2, pp. 67-73, 2006.
46. M. Kadota, H. H. Yang, B. Gomez, et al., "Delineating genetic alterations for tumor progression in theMCF10Aseries of breast cancer cell lines, " PLoS ONE, vol. 5, no. 2, Article IDe9201, 2010.
47. S. H. Kim, F. R. Miller, L. Tait, J. Zheng, and R. F. Novak, "Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression, " International Journal of Cancer, vol. 124, no. 12, pp. 2813-2828, 2009.
48. C. V. Velde, J. Cizeau, D. Dubik, et al., "BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore, " Molecular and Cellular Biology, vol. 20, no. 15, pp. 5454-5468, 2000.
49. H. Yanagisawa, T. Miyashita, Y. Nakano, and D. Yamamoto, "HSpin1, a transmembrane protein interacting with BCl-2/Bcl-XL, induces a caspase-independent autophagic cell death, " Cell Death and Differentiation, vol. 10, no. 7, pp. 798-807, 2003.
50. M. Gentile, M. Ahnstrom, F. Schon, and S. Wingren, "Cand idate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis, " Oncogene, vol. 20, no. 53, pp. 7753-7760, 2001.
51. Y. Tian, Z. Li, W. Hu, et al., "C. elegans screen identifies autophagy genes specific to multicellular organisms, " Cell, vol. 141, no. 6, pp. 1042-1055, 2010.
52. X. Zhao, R. E. Ayer, S. L. Davis, et al., "Apoptosis factor EI24/PIG8 is a novel endoplasmic reticulum-localized Bcl-2-binding protein which is associated with suppression of breast cancer invasiveness, " Cancer Research, vol. 65, no. 6, pp. 2125-2129, 2005.
53. J. M. Zarzynska, "Two faces of TGF-beta1 in breast cancer, " Mediators of Inflammation, vol. 2014, Article ID141747, 16 pages, 2014.
54. V. Karantza-Wadsworth and E. White, "Role of autophagy in breast cancer, " Autophagy, vol. 3, no. 6, pp. 610-613, 2007.
55. E. F. Libby, A. R. Frost, W. Demark-Wahnefried, and D. R. Hurst, "Linking adiponectin and autophagy in the regulation of breast cancer metastasis, " Journal of Molecular Medicine, 2014.
56. E.-J. Lee and C. Tournier, "The requirement of uncoordinated 51-like kinase 1 (ULK1) and ULK2 in the regulation of autophagy, " Autophagy, vol. 7, no. 7, pp. 689-695, 2011.
57. J. Liu, A. Xu, K. S. Lam, et al., "Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency : role of LDL receptor upregulation, " Oncotarget, vol. 4, no. 10, pp. 1804-1818, 2013.
58. L. Pigati, S. C. S. Yaddanapudi, R. Iyengar, et al., "Selective release of MicroRNA species from normal and malignant mammary epithelial cells, " PLoS ONE, vol. 5, no. 10, Article IDe13515, 2010.
59. L. Ciuffreda, C. D. Sanza, U. C. Incani, and M. Milella, "The mTOR pathway: a new target in cancer therapy, " Current Cancer Drug Targets, vol. 10, no. 5, pp. 484-495, 2010.
60. H. Zhu, H. Wu, X. Liu, et al., "Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells, " Autophagy, vol. 5, no. 6, pp. 816-823, 2009.
61. G. Korkmaz, C. le Sage, K. A. Tekirdag, R. Agami, and D. Gozuacik, "miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1, " Autophagy, vol. 8, no. 2, pp. 165-176, 2012.
62. H. Zhai, A. Fesler, and J. Ju, "MicroRNA: a third dimension in autophagy, " Cell Cycle, vol. 12, no. 2, pp. 246-250, 2013.
63. Y. Huang, R. Guerrero-Preston, and E. A. Ratovitski, "Phospho-Np63-dependent regulation of autophagic signaling through transcription and micro-RNA modulation, " Cell Cycle, vol. 11, no. 6, pp. 1247-1259, 2012.
64. L. B. Frankel, J. Wen, M. Lees, et al., "microRNA-101 is a potent inhibitor of autophagy, " The EMBO Journal, vol. 30, no. 22, pp. 4628-4641, 2011.
65. F. Cecconi, "Autophagy regulation by miRNAs: when cleaning goes out of service, "The EMBO Journal, vol. 30, no. 22, pp. 4517-4519, 2011.
66. T. E. Miller, K. Ghoshal, B. Ramaswamy, et al., "MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p271, "The Journal of Biological Chemistry, vol. 283, no. 44, pp. 29897-29903, 2008.
67. M. Garofalo, C. Quintavalle, G. Romano, C. M. Croce, and G. Condorelli, "miR221/222 in cancer: their role in tumor progression and response to therapy, " Current Molecular Medicine, vol. 12, no. 1, pp. 27-33, 2012.
68. Y. H. Huang, P. M. Yang, Q. Y. Chuah, et al., "Autophagy promotes radiation-induced senescence but inhibits bystander effects in human breast cancer cells, " Autophagy, vol. 10, no. 7, pp. 1212-1228, 2014.
69. Y. Kondo, T. Kanzawa, R. Sawaya, and S. Kondo, "The role of autophagy in cancer development and response to therapy, " Nature Reviews Cancer, vol. 5, no. 9, pp. 726-734, 2005.
70. M. A. Qadir, B. Kwok, W. H. Dragowska, et al., "Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization, " Breast Cancer Research and Treatment, vol. 112, no. 3, pp. 389-403, 2008.
71. U. Akar, A. Chaves-Reyez, M. Barria, et al., "Silencing of Bclexpression by small interfering RNA induces autophagic cell death inMCF-7 breast cancer cells, " Autophagy, vol. 4, no. 5, pp. 669-679, 2008.
72. D. A. Gewirtz, "An autophagic switch in the response of tumor cells to radiation and chemotherapy, " Biochemical Pharmacology, vol. 90, no. 3, pp. 208-211, 2014.
73. A. Brech, T. Ahlquist, R. A. Lothe, and H. Stenmark, "Autophagy in tumour suppression and promotion, " Molecular Oncology, vol. 3, no. 4, pp. 366-375, 2009.
74. J. S. Carew, K. R. Kelly, and S. T. Nawrocki, "Autophagy as a target for cancer therapy: new developments, " Cancer Management and Research, vol. 4, no. 1, pp. 357-365, 2012.
75. R. K. Amaravadi, J. Lippincott-Schwartz, X.-M. Yin, et al., "Principles and current strategies for targeting autophagy for cancer treatment, " Clinical Cancer Research, vol. 17, no. 4, pp. 654-666, 2011.
76. K. Garber, "Inducing indigestion: companies embrace autophagy inhibitors, " Journal of the National Cancer Institute, vol. 103, no. 9, pp. 708-710, 2011.
77. J. Rzeszowska-Wolny, W. M. Przybyszewski, and M. Widel, "Ionizing radiation-induced bystander effects, potential targets for modulation of radiotherapy, " European Journal of Pharmacology, vol. 625, no. 1-3, pp. 156-164, 2009.
78. M. Sasaki, M. Miyakoshi, Y. Sato, and Y. Nakanuma, "Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis, " Laboratory Investigation, vol. 90, no. 6, pp. 835-843, 2010.
79. M. L. Bristol, X. Di, M. J. Beckman, et al., "Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitaminD3, " Autophagy, vol. 8, no. 5, pp. 739-753, 2012.
80. X. Sui, R. Chen, Z. Wang, et al., "Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment, " Cell Death and Disease, vol. 4, no. 10, article e838, 2013.
81. D. A. Gewirtz, "The four faces of autophagy: implications for cancer therapy, " Cancer Research, vol. 74, no. 3, pp. 647-651, 2014.
82. A. Ko, A. Kanehisa, I. Martins, et al., "Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling, " Cell Death and Differentiation, vol. 21, no. 1, pp. 92-99, 2014.
83. P. Y. Yeh, S. E. Chuang, K. H. Yeh, Y. C. Song, L. L. Y. Chang, and A. L. Cheng, "Phosphorylation of p53 onThr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death, " Oncogene, vol. 23, no. 20, pp. 3580-3588, 2004.
84. A. Zheng, A. Kallio, and P. Harkonen, "Tamoxifeninduced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen, " Endocrinology, vol. 148, no. 6, pp. 2764-2777, 2007.
85. S. S. Bacus, A. V. Gudkov, M. Lowe, et al., "Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53, " Oncogene, vol. 20, no. 2, pp. 147-155, 2001.
86. D. El-Ashry, D. L. Miller, S. Kharbanda, M. E. Lippman, and F. G. Kern, "Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis, " Oncogene, vol. 15, no. 4, pp. 423-435, 1997.
87. U. Sivaprasad and A. Basu, "Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-κ-induced cell death in MCF-7 cells, " Journal of Cellular and Molecular Medicine, vol. 12, no. 4, pp. 1265-1271, 2008.
88. J. Han, W. Hou, L. A. Goldstein, et al., "Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells, "The Journal of Biological Chemistry, vol. 283, no. 28, pp. 19665-19677, 2008.
89. J. S. Samaddar, V. T. Gaddy, J. Duplantier, et al., "A role for macroautophagy in protection against 4-hydroxytamoxifeninduced cell death and the development of antiestrogen resistance, " Molecular Cancer Therapeutics, vol. 7, no. 9, pp. 2977-2987, 2008.
90. J.-L. Li, S.-H. Han, and X. Fan, "Moderating of autophagy new strategy for anticancer therapy, " Chinese Journal of Cancer, vol. 30, pp. 655-668, 2011.
91. E. Devarajan, J. Chen, A. S. Multani, S. Pathak, A. A. Sahin, and K. Mehta, "Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features, " International Journal of Oncology, vol. 20, no. 5, pp. 913-920, 2002.
92. J. Lu, D. Sun, S. Gao, Y. Gao, J. Ye, and P. Liu, "Cyclovirobuxine D induces autophagy-associated cell death via the Akt/mTOR pathway in MCF-7 human breast cancer cells, " Journal of Pharmacological Sciences, vol. 125, no. 1, pp. 74-82, 2014.
93. C. Lu, W. Wang, Y. Jia, X. Liu, Z. Tong, and B. Li, "Inhibition of AMPK/autophagy potentiates parthenolide-induced apoptosis in human breast cancer cells, " Journal of Cellular Biochemistry, vol. 115, no. 8, pp. 1458-1466, 2014.